Literature DB >> 22057408

A systematic analysis of the theory and practice of syndrome differentiation.

Man Fong Mei1.   

Abstract

Syndrome differentiation is a methodology unique to Chinese medicine. It threads the diagnosis process with clinical treatment into a holistic web of links to determine and regulate the patterns of dysfunctions in the human body. It is seen as the essence of Chinese medicine because it takes into account the theoretical principles, diagnostic methodologies and the modality of treatment holistically. In this process the progressive development and changes of syndromes are also considered by the physician. This paper is a systematic study of the methodology of syndrome differentiation in relation to its clinical applications in the treatment of diseases. To illustrate the efficacy of syndrome differentiation, the relationship between pattern identification and diseases is analysed to provide a guiding principle for integration between Chinese medicine and Western medicine. Diseases being selected include cancer, cardiovascular and metabolic syndromes. A study of renal and hepatic diseases related to lifestyle is also included to highlight the clinical efficacy of syndrome differentiation. The paper also includes an analytical summary of the theoretical advancements made in integrative differentiation methodology during the past five decades which links to the recent clinical thinking and practice.

Entities:  

Mesh:

Year:  2011        PMID: 22057408     DOI: 10.1007/s11655-011-0890-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  5 in total

1.  Integrative medicine: the experience from China.

Authors:  Hao Xu; Keji Chen
Journal:  J Altern Complement Med       Date:  2008 Jan-Feb       Impact factor: 2.579

2.  Study on the tongue manifestations for the blood-stasis and toxin syndrome in the stable patients of coronary heart disease.

Authors:  Yan Feng; Hao Xu; Dan Qu; Feng Zheng; Da-zhuo Shi; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2011-05-25       Impact factor: 1.978

3.  Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.

Authors:  R Hoessel; S Leclerc; J A Endicott; M E Nobel; A Lawrie; P Tunnah; M Leost; E Damiens; D Marie; D Marko; E Niederberger; W Tang; G Eisenbrand; L Meijer
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

4.  Proteomic analysis of chronic restraint stress-induced Gan (肝)-stagnancy syndrome in rats.

Authors:  Xue-gang Sun; Xiao-lan Zhong; Zhi-feng Liu; Hong-bing Cai; Qin Fan; Qi-rui Wang; Qiang Liu; Yu-hong Song; Song-qi He; Xu-fu Zhang; Zhi-ping Lu
Journal:  Chin J Integr Med       Date:  2010-11-26       Impact factor: 1.978

5.  Objectified study on tongue images of patients with lung cancer of different syndromes.

Authors:  Wan Su; Zhen-Ye Xu; Zhong-Qi Wang; Jia-Tuo Xu
Journal:  Chin J Integr Med       Date:  2011-04-21       Impact factor: 1.978

  5 in total
  8 in total

1.  Ranking clinical indicators for stroke pattern identification according to clinical importance in traditional Korean medicine.

Authors:  Tae-Yong Park; Ju Ah Lee; Byoung-Kab Kang; Tae-Woong Moon; Mi Mi Ko; Myeong Soo Lee
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Standardization and future directions in pattern identification research: International brainstorming session.

Authors:  Jeeyoun Jung; Bongki Park; Ju Ah Lee; Sooseong You; Terje Alraek; Zhao-Xiang Bian; Stephen Birch; Tae-Hun Kim; Hao Xu; Chris Zaslawski; Byoung-Kab Kang; Myeong Soo Lee
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

3.  Constitutions of Deficiency and Stasis of Traditional Chinese Medicine and Related Factors among Middle-Aged Women in Taiwan.

Authors:  Ping-Ho Chen; Sheng-Miauh Huang; Jerry Cheng-Yen Lai; Pei-Jung Yu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-19       Impact factor: 2.629

Review 4.  Adaption and application of the four phase trials to traditional chinese medicines.

Authors:  M Y Di; J L Tang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-20       Impact factor: 2.629

5.  Current situation and perspectives of clinical study in integrative medicine in china.

Authors:  Jie Wang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-21       Impact factor: 2.629

6.  ITIH4: A New Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease Patient Identified with Proteomic Method.

Authors:  Hao Xu; Qinghua Shang; Hao Chen; Jianpeng Du; Jianyan Wen; Geng Li; Dazhuo Shi; Keji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-19       Impact factor: 2.629

7.  Prescription patterns of traditional Chinese medicine amongst Taiwanese children: a population-based cohort study.

Authors:  Hwey-Fang Liang; Yao-Hsu Yang; Pau-Chung Chen; Hsing-Chun Kuo; Chia-Hao Chang; Ying-Hsiang Wang; Kuang-Ming Wu
Journal:  BMC Complement Altern Med       Date:  2018-06-22       Impact factor: 3.659

Review 8.  Traditional Chinese Medicine for Post-Stroke Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Wei Shen; Xueming Fan; Liuding Wang; Yunling Zhang
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.